OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
Nuray Çakici, Arjen L. Sutterland, Brenda W.J.H. Penninx, et al.
Psychological Medicine (2021) Vol. 51, Iss. 4, pp. 538-549
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis
Yuan Zhang, Jingjing Wang, Yu Ye, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 125, pp. 110740-110740
Closed Access | Times Cited: 80

The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses
Daniele Cavaleri, Federico Moretti, Alessandra Bartoccetti, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105159-105159
Open Access | Times Cited: 70

Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 12

Potential Benefits of Ketone Therapy as a Novel Immunometabolic Treatment for Schizophrenia
Karin Huizer, Shubham Soni, M. Schmidt, et al.
Psychiatry Research (2025) Vol. 345, pp. 116379-116379
Open Access | Times Cited: 1

Changes in leukocytes and CRP in different stages of major depression
Deepti Singh, Paul C. Guest, Henrik Dobrowolny, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 29

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study
Ke Xu, Peng Zheng, Shuang Zhao, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12

Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder
Lewei Liu, Xiaoxue Yang, Cheng Yang, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 110-117
Closed Access | Times Cited: 4

Are There Biological Correlates of Response to Yoga-Based Interventions in Depression? A Critical Scoping Review
Ravi Philip Rajkumar
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 543-543
Open Access | Times Cited: 4

Overexpression of Hspa1b in the Mouse Hippocampus Is Associated with Major Depressive Disorder
Xiaofeng Zhao, Y Z Shang, Wenli Zhu, et al.
Research Square (Research Square) (2025)
Closed Access

Electroconvulsive Therapy Changes Peripheral Blood Neurotrophic and Inflammatory Markers in Depressed Patients
Nadia Falhani, Lisa-Marie Brunner, D Melchner, et al.
Journal of Ect (2025)
Closed Access

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
Rachel Shvartsur, Galila Agam, Sarit Uzzan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 901-901
Open Access | Times Cited: 13

Immune-inflammatory markers of response to repetitive transcranial magnetic stimulation in depression: A scoping review
Ravi Philip Rajkumar
Asian Journal of Psychiatry (2023) Vol. 91, pp. 103852-103852
Closed Access | Times Cited: 7

Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up
Dongmei Han, Daliang Sun, Meihong Xiu, et al.
Psychoneuroendocrinology (2021) Vol. 133, pp. 105392-105392
Closed Access | Times Cited: 13

Levels of cytokines in the cerebrospinal fluid of patients with psychotic disorders compared to individually matched healthy controls
Rose Jeppesen, Nis Borbye‐Lorenzen, Rune Haubo Bojesen Christensen, et al.
Brain Behavior and Immunity (2023) Vol. 117, pp. 167-174
Open Access | Times Cited: 4

The Influence of Gut Microbiota in Psychosis
Nuala Murray, Reza Hosseini Ghomi, Katlyn Nemani, et al.
Elsevier eBooks (2024), pp. 161-199
Closed Access | Times Cited: 1

Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Ravi Philip Rajkumar
Exploration of Neuroprotective Therapy (2024), pp. 11-37
Open Access | Times Cited: 1

Potential Benefits of Ketone Therapy as a Novel Immunometabolic Treatment for Schizophrenia
Karin Huizer, Shubham Soni, M. Schmidt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Dynamic Real‐Time Biosensing Enabled Biorhythm Tracking for Psychiatric Disorders
Karin Huizer, Ivneet Banga, Ruchita Mahesh Kumar, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access | Times Cited: 1

The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study
Jeanette Brun Larsen, Solveig Klæbo Reitan, Else‐Marie Løberg, et al.
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100392-100392
Open Access | Times Cited: 9

Role of Neuroglia in the Habenular Connection Hub of the Dorsal Diencephalic Conduction System
A.J.M. Loonen
Neuroglia (2023) Vol. 4, Iss. 1, pp. 34-51
Open Access | Times Cited: 3

Negative symptoms and neurocognition in drug-naïve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-γ)
Meijuan Li, Guoshuai Luo, Yuying Qiu, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 5, pp. 1071-1081
Closed Access | Times Cited: 3

Effects of Dexamethasone and Pentoxifylline on Mania-like and Depression-like Behaviors in Rats
Ahmad Nassar, Abed N. Azab
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1063-1063
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top